Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 3/2006

01-05-2006 | Case Report

Hypertrophic pachymeningitis and undifferentiated connective tissue disease: a case report and review of the literature

Authors: Christos E. Lampropoulos, Mollyza Zain, Wajanat Jan, Ali Nader-Sepahi, Ian H. Sabin, David P. D' Cruz

Published in: Clinical Rheumatology | Issue 3/2006

Login to get access

Abstract

A 63-year-old man with hypertrophic pachymeningitis (HP) and an undifferentiated connective tissue disease is described. Combined therapy with prednisolone and azathioprine improved his symptoms. The association between an undifferentiated connective tissue disease and HP is discussed.
Literature
1.
Spencer WH (1879) Case of idiopathic inflammation of the spinal dura mater (pachymeningitis spinalis externa). Lancet I:836–837CrossRef
2.
Ranoux D, Devaux B, Lamy C, Mear JK, Roux FX, Mas JL (1992) Meningeal sarcoidosis, pseudo-meningioma and pachymeningitis of the convexity. J Neurol Neurosurg Psychiatry 55:300–303PubMedCrossRef
3.
Nagashima T, Maguchi S, Terayama Y et al (2000) P-ANCA-positive Wegener's granulomatosis presenting with hypertrophy pachymeningitis and multiple cranial neuropathies: case report and review of literature. Neuropathology 20:23–28CrossRefPubMed
4.
Li JY, Lai PH, Lam HC et al (1999) Hypertrophic cranial pachymeningitis and lymphocytic hypophysitis in Sjogren's syndrome. Neurology 52:420–423PubMed
5.
Yuh WT, Drew JM, Rizzo M, Ryals TJ, Sato Y, Bell WE (1990) Evaluation of pachymeningitis by contrast-enhanced MR imaging in a patient with rheumatoid disease. Am J Neuroradiol 11:1247–1248PubMed
6.
Kono H, Inokuma S, Nakayama H, Yamazaki J (2000) Pachymeningitis in microscopic polyangiitis (MPA): a case report and a review of central nervous system involvement in MPA. Clin Exp Rheumatol 18:397–400PubMed
7.
Fujimoto M, Kira J, Murai H, Yoshimura T, Takizawa K, Goto I (1993) Hypertrophic cranial pachymeningitis associated with mixed connective tissue disease; a comparison with idiopathic and infectious pachymeningitis. Int Med 32:510–512CrossRef
8.
Takuma H, Shimada H, Inoue Y et al (2001) Hypertrophic pachymeningitis with anti-neutrophil cytoplasmic antibody (p-ANCA) and diabetes insipidus. Acta Neurol Scand 104:397–399CrossRefPubMed
9.
Lam BL, Barrett DA, Glaser JS, Schatz NJ, Brown HH (1994) Visual loss from idiopathic intracranial pachymeningitis. Neurology 44:694–698PubMed
10.
Nishioka H, Ito H, Haraoka J, Yamada Y, Nojima H (1998) Idiopathic hypertrophic cranial pachymeningitis with accumulation of thallium-201 on single-photon emission CT. Am J Neuroradiol 19:450–453PubMed
Metadata
Title
Hypertrophic pachymeningitis and undifferentiated connective tissue disease: a case report and review of the literature
Authors
Christos E. Lampropoulos
Mollyza Zain
Wajanat Jan
Ali Nader-Sepahi
Ian H. Sabin
David P. D' Cruz
Publication date
01-05-2006
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 3/2006
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-0018-z

Other articles of this Issue 3/2006

Clinical Rheumatology 3/2006 Go to the issue

Case Report

Catastrophic thromboses and severe thrombocytopenia during heparin therapy in a patient with anti-phospholipid syndrome

Original Article

Prior anti-dsDNA antibody status does not predict later disease manifestations in systemic lupus erythematosus

Case Report

Magnetic resonance imaging in the differential diagnosis between polymyalgia rheumatica and elderly onset rheumatoid arthritis

Case Report

Transient global amnesia in a patient with high and persistent levels of antiphospholipid antibodies

Original Article

Incidence and clinical correlation of anticentromere antibody in Thai patients

Case Report

Lethal acute respiratory distress syndrome during anti-TNF-α therapy for rheumatoid arthritis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits